Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2021
Basilea provides 2021 financial guidance
Basilea provided financial guidance for full-year 2021, including expected non-deferred revenue contributions from Cresemba and Zevtera of CHF 108–118 million and year-end cash and investments of approximately CHF 110–120 million.
2020
Basilea reports half-year 2020 results
Basilea Pharmaceutica announced financial results for the six months ended June 30, 2020, reporting revenue of CHF 69.3 million, operating profit of CHF 12.8 million and net profit of CHF 9.9 million.
2020
Basilea launches convertible bond placement
Basilea announced the launch of a placement of CHF 100 million in senior unsecured convertible bonds due 2027, with an increase option of up to CHF 25 million. It said proceeds would finance a planned tender offer for its outstanding 2022 convertible bonds and general corporate purposes.